We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$94.2M
AUM Growth
+$7.66M
Cap. Flow
+$4.36M
Cap. Flow %
4.62%
Top 10 Hldgs %
41.69%
Holding
106
New
19
Increased
31
Reduced
29
Closed
25

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.36M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.19M
3
BABA icon
Alibaba
BABA
+$1.84M
4
CRM icon
Salesforce
CRM
+$1.69M
5
DIS icon
Walt Disney
DIS
+$1.65M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.9M
2
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$1.43M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$1.16M
4
AMZN icon
Amazon
AMZN
+$1.09M
5
LYV icon
Live Nation Entertainment
LYV
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Technology 14.03%
3 Communication Services 6.74%
4 Consumer Discretionary 5.25%
5 Financials 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONCE
76
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$97K 0.1%
948
-2,926
-76% -$316K
TW icon
77
Tradeweb Markets
TW
$21.8B
$93K 0.1%
+2,132
New +$89K
EQ icon
78
Equillium
EQ
$135M
$39K 0.04%
6,932
+6
+0.1% +$38
SNNA
79
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$12K 0.01%
13,260
+13
+0.1% +$20
A icon
80
Agilent Technologies
A
$39.9B
– –
-5,623
Closed -$452K
AMZN icon
81
Amazon
AMZN
$2.96T
– –
-12,200
Closed -$1.09M
APTV icon
82
Aptiv
APTV
$9.95B
– –
-12,375
Closed -$984K
ARAY icon
83
Accuray
ARAY
$36.7M
– –
-10,037
Closed -$48K
BPMC
84
DELISTED
Blueprint Medicines
BPMC
– –
-9,766
Closed -$782K
EW icon
85
CALL
Edwards Lifesciences
EW
$51.3B
– –
-9,000
Closed -$574K
GOOGL icon
86
Alphabet (Google) Class A
GOOGL
$4.37T
– –
-13,240
Closed -$779K
HUM icon
87
CALL
Humana
HUM
$43.8B
– –
-8,200
Closed -$2.18M
LYFT icon
88
Lyft
LYFT
$6.39B
– –
-2,792
Closed -$219K
LYV icon
89
Live Nation Entertainment
LYV
$42.4B
– –
-16,256
Closed -$1.03M
NXPI icon
90
NXP Semiconductors
NXPI
$60.3B
– –
-11,400
Closed -$1.01M
PTCT icon
91
PTC Therapeutics
PTCT
$5.99B
– –
-11,083
Closed -$417K
SAGE
92
DELISTED
Sage Therapeutics
SAGE
– –
-2,138
Closed -$340K
SHOP icon
93
Shopify
SHOP
$190B
– –
-6,200
Closed -$128K
UBX
94
DELISTED
Unity Biotechnology
UBX
– –
-596
Closed -$48K
WVE icon
95
Wave Life Sciences
WVE
$1.21B
– –
-7,383
Closed -$287K
ZLAB icon
96
Zai Lab
ZLAB
$2.44B
– –
-6
Closed –
GRTS
97
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-8,749
Closed -$116K
SPLK
98
DELISTED
Splunk Inc
SPLK
– –
-2,848
Closed -$355K
MRTX
99
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-1,309
Closed -$96K
APTX
100
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-13,614
Closed -$55K
1 2 3
4
5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Partner Investment Management held 106 positions worth $94.2M, up 8.9% from $86.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Partner Investment Management deployed $4.36M of net new capital in Q2 2019, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 25,610 shares worth $2.19M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $1.9M trimmed.

  • Partner Investment Management's largest Q2 2019 buy was BioMarin Pharmaceuticals: 25,610 shares worth $2.19M.
  • Partner Investment Management added most to Allergan plc in Q2 2019, an estimated $2.36M increase.
  • Partner Investment Management's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $1.9M.
  • Partner Investment Management fully exited Amazon in Q2 2019, selling an estimated $1.09M.
  • Partner Investment Management's ten largest holdings make up 42% of its $94.2M portfolio in Q2 2019.
  • Partner Investment Management opened 19 new positions and closed 25 in Q2 2019.
  • Partner Investment Management's portfolio value rose 8.9% quarter-over-quarter to $94.2M.

Based on Partner Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.